What is Definitive Healthcare Corp.'s earnings per share (EPS)?

Definitive Healthcare Corp. (DH) reported diluted earnings per share of $-1.30 for fiscal year 2025. This represents a 63.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Definitive Healthcare Corp. Financials

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Definitive Healthcare Corp. (DH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DH FY2025 2026-05-07

Definitive Healthcare’s core business still converts revenue into cash, but reported losses mainly reflect a shrinking intangible-asset base.

Across the last three years, operating cash flow stayed positive while goodwill fell from $1.08B to $197.2M, even with very large net losses. That combination suggests the headline losses were driven far more by non-cash balance-sheet resets than by the customer engine failing to collect cash.

The company still shows high gross-margin economics: gross margin held near 76% in FY2025 even as revenue softened, so the operating problem sits mostly above gross profit, not in delivery costs. With R&D plus SG&A still about $86.4M, expense control has improved the loss profile but has not yet fully aligned the cost base with current sales.

The balance-sheet cushion has thinned: the current ratio moved from 2.3x to 1.6x, and cash now only modestly exceeds long-term debt. That makes free cash flow of $37.1M more important as internal financing for debt reduction and liquidity support than as proof of accelerating scale.

Financial Health Signals

Financial Profile 36/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Definitive Healthcare Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Definitive Healthcare Corp. has an operating margin of -92.9%, meaning the company retains $-93 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -281.8% the prior year.

Growth

Definitive Healthcare Corp.'s revenue declined 4.2% year-over-year, from $252.2M to $241.5M. This contraction results in a growth score of 30/100.

Leverage

Definitive Healthcare Corp. carries a low D/E ratio of 0.41, meaning only $0.41 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 94/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Definitive Healthcare Corp.'s current ratio of 1.64 is below the typical benchmark, resulting in a score of 29/100. However, the company holds substantial cash reserves (104% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.

Cash Flow

Definitive Healthcare Corp. converts 15.3% of revenue into free cash flow ($37.1M). This strong cash generation earns a score of 65/100.

Returns

Definitive Healthcare Corp. generates a -36.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -68.0% the prior year.

Piotroski F-Score Neutral

4/9

Definitive Healthcare Corp. passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-0.39x

For every $1 of reported earnings, Definitive Healthcare Corp. generates $-0.39 in operating cash flow ($53.8M OCF vs -$138.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-19.9x

Definitive Healthcare Corp. earns $-19.9 in operating income for every $1 of interest expense (-$224.3M vs $11.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$241.5M

YoY-4.2%

5Y CAGR+15.3%

Definitive Healthcare Corp. generated $241.5M in revenue in fiscal year 2025. This represents a decrease of 4.2% from the prior year.

EBITDA

-$221.0M

YoY+68.8%

Definitive Healthcare Corp.'s EBITDA was -$221.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 68.8% from the prior year.

Net Income

-$138.9M

YoY+66.4%

Definitive Healthcare Corp. reported -$138.9M in net income in fiscal year 2025. This represents an increase of 66.4% from the prior year.

EPS (Diluted)

$-1.30

YoY+63.3%

Definitive Healthcare Corp. earned $-1.30 per diluted share (EPS) in fiscal year 2025. This represents an increase of 63.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$37.1M

YoY-19.2%

5Y CAGR+11.2%

Definitive Healthcare Corp. generated $37.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 19.2% from the prior year.

Cash & Debt

$163.6M

YoY+55.3%

5Y CAGR+45.9%

Definitive Healthcare Corp. held $163.6M in cash against $156.1M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

75.9%

YoY-2.4pp

5Y CAGR+1.6pp

Definitive Healthcare Corp.'s gross margin was 75.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.4 percentage points from the prior year.

Operating Margin

-92.9%

YoY+189.0pp

5Y CAGR-79.4pp

Definitive Healthcare Corp.'s operating margin was -92.9% in fiscal year 2025, reflecting core business profitability. This is up 189.0 percentage points from the prior year.

Net Margin

-57.5%

YoY+106.3pp

5Y CAGR-57.5pp

Definitive Healthcare Corp.'s net profit margin was -57.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 106.3 percentage points from the prior year.

Return on Equity

-36.7%

YoY+31.4pp

5Y CAGR-36.7pp

Definitive Healthcare Corp.'s ROE was -36.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 31.4 percentage points from the prior year.

Capital Allocation

R&D Spending

$34.8M

YoY-4.8%

5Y CAGR+25.7%

Definitive Healthcare Corp. invested $34.8M in research and development in fiscal year 2025. This represents a decrease of 4.8% from the prior year.

Share Buybacks

$49.5M

YoY+121.1%

Definitive Healthcare Corp. spent $49.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 121.1% from the prior year.

Capital Expenditures

$16.7M

YoY+35.5%

5Y CAGR+64.3%

Definitive Healthcare Corp. invested $16.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 35.5% from the prior year.

DH Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$241.5M-4.2%	$252.2M+0.3%	$251.4M+12.9%	$222.7M+34.0%	$166.2M+40.4%	$118.3M
Cost of Revenue	$58.2M+6.4%	$54.7M+15.3%	$47.5M+11.4%	$42.6M+119.5%	$19.4M+75.2%	$11.1M
Gross Profit	$183.3M-7.2%	$197.5M-3.2%	$203.9M+13.3%	$180.0M+43.5%	$125.5M+42.8%	$87.8M
R&D Expenses	$34.8M-4.8%	$36.5M-14.0%	$42.4M+21.6%	$34.9M+87.9%	$18.6M+67.8%	$11.1M
SG&A Expenses	$51.6M+4.8%	$49.3M-16.3%	$58.9M+14.2%	$51.6M+56.9%	$32.9M+128.7%	$14.4M
Operating Income	-$224.3M+68.4%	-$710.8M-115.5%	-$329.8M-648.8%	-$44.0M-61.2%	-$27.3M-72.0%	-$15.9M
Interest Expense	$11.3M-23.9%	$14.8M-2.4%	$15.2M+35.7%	$11.2M-56.8%	$25.9M-29.0%	$36.5M
Income Tax	-$10.0M+76.5%	-$42.3M-128.0%	-$18.6M-4.8%	-$17.7M-3895.0%	-$443K	$0
Net Income	-$138.9M+66.4%	-$413.1M-104.1%	-$202.4M-2702.4%	-$7.2M+59.5%	-$17.8M	$0
EPS (Diluted)	$-1.30+63.3%	$-3.54-97.8%	$-1.79-2457.1%	$-0.07+63.2%	$-0.19	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$55.9M-9.1%	$61.5M+2.5%	$60.0M-1.2%	$60.8M+2.6%	$59.2M-5.0%	$62.3M-0.7%	$62.7M-1.6%	$63.7M
Cost of Revenue	$14.3M-2.4%	$14.6M+4.1%	$14.1M-0.6%	$14.1M-8.4%	$15.4M+5.1%	$14.7M+7.5%	$13.7M+2.9%	$13.3M
Gross Profit	$41.6M-11.2%	$46.9M+2.0%	$46.0M-1.3%	$46.6M+6.5%	$43.8M-8.1%	$47.6M-2.9%	$49.0M-2.8%	$50.5M
R&D Expenses	$6.5M-34.7%	$10.0M+31.8%	$7.6M-5.2%	$8.0M-14.3%	$9.3M+3.6%	$9.0M+23.3%	$7.3M-28.1%	$10.1M
SG&A Expenses	$12.1M-15.6%	$14.3M+15.8%	$12.4M-2.4%	$12.7M+3.3%	$12.3M+44.3%	$8.5M-25.1%	$11.4M-9.4%	$12.5M
Operating Income	-$201.3M-656.0%	-$26.6M-206.5%	-$8.7M-108.3%	-$4.2M+97.7%	-$184.8M-85.6%	-$99.6M+55.8%	-$225.4M+39.0%	-$369.6M
Interest Expense	$2.6M-8.3%	$2.9M-4.4%	$3.0M+0.3%	$3.0M+22.9%	$2.4M-30.7%	$3.5M-6.4%	$3.7M-0.4%	$3.8M
Income Tax	-$3.4M-6381.1%	-$53K-110.1%	$524K+14.9%	$456K+104.2%	-$10.9M-84.7%	-$5.9M+57.0%	-$13.7M+37.3%	-$21.9M
Net Income	-$138.6M-1388.1%	-$9.3M+37.2%	-$14.8M-96.5%	-$7.6M+93.0%	-$107.2M-81.5%	-$59.1M+54.9%	-$130.9M+38.7%	-$213.6M
EPS (Diluted)	$-1.32	N/A	$-0.14-100.0%	$-0.07+92.6%	$-0.95	N/A	$-1.12+38.1%	$-1.81

DH Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$735.5M-32.5%	$1.1B-40.3%	$1.8B-14.0%	$2.1B+0.2%	$2.1B+21.2%	$1.7B
Current Assets	$257.6M-30.4%	$370.2M-6.0%	$393.9M-4.8%	$413.7M-6.9%	$444.2M+595.8%	$63.8M
Cash & Equivalents	$163.6M+55.3%	$105.4M-19.5%	$131.0M-10.9%	$146.9M-62.1%	$387.5M+1464.1%	$24.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$52.0M-2.4%	$53.2M-10.2%	$59.2M+0.8%	$58.8M+35.7%	$43.3M+30.9%	$33.1M
Goodwill	$197.2M-49.9%	$393.3M-63.4%	$1.1B-18.8%	$1.3B+4.9%	$1.3B0.0%	$1.3B
Total Liabilities	$356.5M-26.1%	$482.2M-23.1%	$626.7M-2.2%	$640.7M+3.7%	$617.8M+11.4%	$554.4M
Current Liabilities	$156.8M-2.7%	$161.2M-5.6%	$170.7M+21.4%	$140.6M+14.2%	$123.1M+34.9%	$91.3M
Long-Term Debt	$156.1M-31.9%	$229.4M-5.4%	$242.6M-5.2%	$255.8M-3.0%	$263.8M-42.3%	$457.2M
Total Equity	$379.0M-37.6%	$607.2M-49.4%	$1.2B-19.1%	$1.5B-1.2%	$1.5B+25.8%	$1.2B
Retained Earnings	-$779.5M-21.7%	-$640.6M-181.6%	-$227.4M-807.5%	-$25.1M-40.5%	-$17.8M	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$514.7M-30.0%	$735.5M-2.7%	$755.5M-1.9%	$770.1M-4.8%	$808.7M-25.8%	$1.1B-7.8%	$1.2B-16.9%	$1.4B
Current Assets	$245.8M-4.6%	$257.6M+4.6%	$246.3M-1.2%	$249.2M-8.9%	$273.4M-26.1%	$370.2M+0.4%	$368.7M+0.1%	$368.3M
Cash & Equivalents	$157.6M-3.7%	$163.6M+51.1%	$108.3M+33.8%	$81.0M-23.7%	$106.1M+0.7%	$105.4M-23.4%	$137.6M+13.8%	$120.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$38.9M-25.1%	$52.0M+51.2%	$34.4M-8.4%	$37.5M-12.6%	$42.9M-19.4%	$53.2M+48.9%	$35.8M-19.1%	$44.2M
Goodwill	$0-100.0%	$197.2M-9.0%	$216.8M0.0%	$216.8M0.0%	$216.8M-44.9%	$393.3M-19.8%	$490.3M-31.8%	$718.5M
Total Liabilities	$324.0M-9.1%	$356.5M-2.6%	$365.9M+1.9%	$358.9M-3.7%	$372.8M-22.7%	$482.2M-0.8%	$486.1M-9.3%	$536.1M
Current Liabilities	$140.4M-10.5%	$156.8M+1.9%	$153.9M+1.7%	$151.3M-3.1%	$156.1M-3.2%	$161.2M+8.8%	$148.2M-3.5%	$153.5M
Long-Term Debt	$154.0M-1.3%	$156.1M-1.3%	$158.2M-1.3%	$160.3M-1.3%	$162.4M-29.2%	$229.4M-1.4%	$232.7M-1.4%	$236.0M
Total Equity	$190.7M-49.7%	$379.0M-2.7%	$389.7M-5.2%	$411.2M-5.7%	$435.9M-28.2%	$607.2M-12.7%	$695.6M-21.5%	$886.3M
Retained Earnings	-$918.1M-17.8%	-$779.5M-1.2%	-$770.2M-2.0%	-$755.4M-1.0%	-$747.8M-16.7%	-$640.6M-10.2%	-$581.5M-29.0%	-$450.6M

DH Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$53.8M-7.6%	$58.2M+41.3%	$41.2M+15.8%	$35.6M+41.1%	$25.2M+8.6%	$23.2M
Capital Expenditures	$16.7M+35.5%	$12.3M+314.6%	$3.0M-64.2%	$8.3M+23.7%	$6.7M+382.5%	$1.4M
Free Cash Flow	$37.1M-19.2%	$45.9M+20.0%	$38.2M+40.2%	$27.3M+47.5%	$18.5M-15.3%	$21.8M
Investing Cash Flow	$153.9M+682.7%	-$26.4M+16.9%	-$31.8M+87.2%	-$248.9M-432.6%	-$46.7M-95.8%	-$23.9M
Financing Cash Flow	-$150.8M-165.7%	-$56.7M-121.8%	-$25.6M+4.2%	-$26.7M-106.9%	$384.4M+2207.8%	$16.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$49.5M+121.1%	$22.4M	$0	$0-100.0%	$231.8M	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$11.6M+325.1%	$2.7M-82.7%	$15.7M+68.6%	$9.3M-64.3%	$26.1M+220.4%	$8.1M-58.1%	$19.4M+38.4%	$14.0M
Capital Expenditures	$3.2M-27.9%	$4.4M+94.7%	$2.3M-0.5%	$2.3M-70.2%	$7.7M-29.3%	$10.9M+1321.3%	$767K+87.1%	$410K
Free Cash Flow	$8.4M+586.2%	-$1.7M-112.8%	$13.4M+91.2%	$7.0M-61.8%	$18.4M+763.8%	-$2.8M-114.8%	$18.7M+36.9%	$13.6M
Investing Cash Flow	-$6.2M-111.0%	$56.4M+133.4%	$24.1M+337.6%	-$10.2M-112.2%	$83.5M+418.0%	-$26.3M-393.2%	$9.0M-40.0%	$14.9M
Financing Cash Flow	-$10.9M-178.1%	-$3.9M+68.6%	-$12.5M+49.5%	-$24.7M+77.5%	-$109.7M-720.7%	-$13.4M-10.8%	-$12.1M+14.6%	-$14.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0	$0-100.0%	$9.2M-51.7%	$19.1M-9.8%	$21.2M+188.6%	$7.3M-8.8%	$8.0M+14.7%	$7.0M

DH Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	75.9%-2.4pp	78.3%-2.8pp	81.1%+0.3pp	80.9%+5.3pp	75.5%+1.3pp	74.3%
Operating Margin	-92.9%+189.0pp	-281.8%-150.7pp	-131.2%-111.4pp	-19.8%-3.3pp	-16.4%-3.0pp	-13.4%
Net Margin	-57.5%+106.3pp	-163.8%-83.3pp	-80.5%-77.3pp	-3.2%+7.5pp	-10.7%-10.7pp	0.0%
Return on Equity	-36.7%+31.4pp	-68.0%-51.2pp	-16.9%-16.4pp	-0.5%+0.7pp	-1.2%-1.2pp	0.0%
Return on Assets	-18.9%+19.0pp	-37.9%-26.8pp	-11.1%-10.7pp	-0.3%+0.5pp	-0.8%-0.8pp	0.0%
Current Ratio	1.64-0.7	2.30-0.0	2.31-0.6	2.94-0.7	3.61+2.9	0.70
Debt-to-Equity	0.41+0.0	0.38+0.2	0.20+0.0	0.170.0	0.18-0.2	0.38
FCF Margin	15.3%-2.8pp	18.2%+3.0pp	15.2%+3.0pp	12.2%+1.1pp	11.1%-7.3pp	18.4%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	74.5%-1.8pp	76.2%-0.4pp	76.6%-0.1pp	76.7%+2.8pp	73.9%-2.5pp	76.4%-1.8pp	78.2%-1.0pp	79.2%
Operating Margin	-359.9%-316.6pp	-43.3%-28.8pp	-14.5%-7.6pp	-6.9%+305.3pp	-312.2%-152.3pp	-159.8%+199.6pp	-359.4%+220.5pp	-580.0%
Net Margin	-247.8%-232.7pp	-15.1%+9.6pp	-24.7%-12.3pp	-12.4%+168.7pp	-181.2%-86.3pp	-94.8%+113.9pp	-208.8%+126.4pp	-335.2%
Return on Equity	-72.7%-70.2pp	-2.5%+1.4pp	-3.8%-2.0pp	-1.8%+22.8pp	-24.6%-14.9pp	-9.7%+9.1pp	-18.8%+5.3pp	-24.1%
Return on Assets	-26.9%-25.7pp	-1.3%+0.7pp	-2.0%-1.0pp	-1.0%+12.3pp	-13.3%-7.8pp	-5.4%+5.7pp	-11.1%+3.9pp	-15.0%
Current Ratio	1.75+0.1	1.64+0.0	1.60-0.0	1.65-0.1	1.75-0.5	2.30-0.2	2.49+0.1	2.40
Debt-to-Equity	0.81+0.4	0.410.0	0.41+0.0	0.39+0.0	0.370.0	0.38+0.0	0.33+0.1	0.27
FCF Margin	14.9%+17.8pp	-2.8%-25.1pp	22.3%+10.8pp	11.5%-19.5pp	31.0%+35.5pp	-4.4%-34.2pp	29.8%+8.4pp	21.4%

Similar Companies

Talkspace Inc TALK

$871.1M

National Resh Corp NRC

$429.1M

Optimizerx Corp OPRX

$90.6M

So-Young Intl SY

$220.7M

Spok Hldgs Inc SPOK

$224.1M

Frequently Asked Questions

What is Definitive Healthcare Corp.'s annual revenue?

Definitive Healthcare Corp. (DH) reported $241.5M in total revenue for fiscal year 2025. This represents a -4.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Definitive Healthcare Corp.'s revenue growing?

Definitive Healthcare Corp. (DH) revenue declined by 4.2% year-over-year, from $252.2M to $241.5M in fiscal year 2025.

Is Definitive Healthcare Corp. profitable?

No, Definitive Healthcare Corp. (DH) reported a net income of -$138.9M in fiscal year 2025, with a net profit margin of -57.5%.

What is Definitive Healthcare Corp.'s EBITDA?

Definitive Healthcare Corp. (DH) had EBITDA of -$221.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Definitive Healthcare Corp. have?

As of fiscal year 2025, Definitive Healthcare Corp. (DH) had $163.6M in cash and equivalents against $156.1M in long-term debt.

What is Definitive Healthcare Corp.'s gross margin?

Definitive Healthcare Corp. (DH) had a gross margin of 75.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Definitive Healthcare Corp.'s operating margin?

Definitive Healthcare Corp. (DH) had an operating margin of -92.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Definitive Healthcare Corp.'s net profit margin?

Definitive Healthcare Corp. (DH) had a net profit margin of -57.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Definitive Healthcare Corp.'s return on equity (ROE)?

Definitive Healthcare Corp. (DH) has a return on equity of -36.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Definitive Healthcare Corp.'s free cash flow?

Definitive Healthcare Corp. (DH) generated $37.1M in free cash flow during fiscal year 2025. This represents a -19.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Definitive Healthcare Corp.'s operating cash flow?

Definitive Healthcare Corp. (DH) generated $53.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Definitive Healthcare Corp.'s total assets?

Definitive Healthcare Corp. (DH) had $735.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Definitive Healthcare Corp.'s capital expenditures?

Definitive Healthcare Corp. (DH) invested $16.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Definitive Healthcare Corp. spend on research and development?

Definitive Healthcare Corp. (DH) invested $34.8M in research and development during fiscal year 2025.

Does Definitive Healthcare Corp. buy back shares?

Yes, Definitive Healthcare Corp. (DH) spent $49.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is Definitive Healthcare Corp.'s current ratio?

Definitive Healthcare Corp. (DH) had a current ratio of 1.64 as of fiscal year 2025, which is generally considered healthy.

What is Definitive Healthcare Corp.'s debt-to-equity ratio?

Definitive Healthcare Corp. (DH) had a debt-to-equity ratio of 0.41 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Definitive Healthcare Corp.'s return on assets (ROA)?

Definitive Healthcare Corp. (DH) had a return on assets of -18.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Definitive Healthcare Corp.'s Piotroski F-Score?

Definitive Healthcare Corp. (DH) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Definitive Healthcare Corp.'s earnings high quality?

Definitive Healthcare Corp. (DH) has an earnings quality ratio of -0.39x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Definitive Healthcare Corp. cover its interest payments?

Definitive Healthcare Corp. (DH) has an interest coverage ratio of -19.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Definitive Healthcare Corp.?

Definitive Healthcare Corp. (DH) scores 36 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.